
Topic
Specialty Pharmacy
Limited distribution, hub services, fulfillment routing, REMS friction, and payer-channel coordination.

Deals· August 3, 2026 · 15 min read
By Ran Chen#M&A#Rare Disease#Orange Book

Pricing & Access· August 1, 2026 · 23 min read
Parkinson's Disease Treatment Access: From $0.08 Levodopa to Tavapadon

Pricing & Access· July 31, 2026 · 22 min read
Radioligand Therapy Access Landscape: Pluvicto, Lutathera & ITM PDUFA
By Ran Chen#Market Access#FDA Approval#HCPCS Coding

Specialty· July 29, 2026 · 24 min read
Hereditary Angioedema Treatment Access Landscape (2026)

Pricing & Access· July 27, 2026 · 18 min read
Multiple Sclerosis Disease-Modifying Therapy Access Landscape (2026)
By Ran Chen#Multiple Sclerosis#Biosimilars#Patent Cliff

Approvals· July 27, 2026 · 18 min read
Sickle Cell Disease Treatment Access Landscape: Casgevy, Lyfgenia & Oxbryta

Deals· July 22, 2026 · 18 min read
Vertex's $10B Crinetics Acquisition: Paltusotine and Rare Endocrine Bet
By Ran Chen#M&A#Orphan Drug#Rare Disease

Pricing & Access· July 18, 2026 · 18 min read
Sarclisa Escena SC access: CirCLIQ on-body injector, trial data, and billing
By Ran Chen#Oncology#FDA Approval#Specialty Pharmacy

Policy· July 17, 2026 · 18 min read
Certificate-of-Need Laws in 2026: The Specialty Drug Site-of-Care Gate

Pricing & Access· July 16, 2026 · 23 min read